文献速递胸部肿瘤

从不吸烟者肺癌:遗传、流行病学、环境暴露与独特免疫景观

Lung Cancer in Never Smokers: Genetics, Epidemiology, Environmental Exposures, and Distinct Immune Landscape.
PubMed 文献 · J Thorac Oncol · 2026-04-01

综述聚焦从不吸烟者肺癌(LCINS),其好发于年轻女性和东亚人群,具独特遗传易感性、环境暴露和分子改变。家族史使一级亲属发病风险增高1.7倍,亚洲从不吸烟者基线发病率是非亚洲者的2.3倍。筛查试验检出率与吸烟者试验相当,提示部分亚组可从筛查获益。

要点

  • 女性与亚洲 ethnicity 是独立危险因素,多变量分析中超过家族史。
  • 亚洲女性从不吸烟者肺癌检出率与亚洲男性曾吸烟者相当。
  • PM2.5暴露升高东亚人群LCINS发病与死亡,且与EGFR突变率升高并存。

核心结论

  • 从不吸烟者肺癌负担上升且具可识别高危亚组,但当前筛查指南仍排除该人群。
  • 该人群可靶向驱动基因高发,早期检测可获益,而免疫检查点抑制剂反应常较低。

研究设计与样本

  • 综述,汇总LCINS流行病学、遗传易感性、分子改变、环境危险因素与肿瘤免疫学证据。

主要发现

  • 一级亲属受累者肺癌发病率增高1.7倍。
  • 女性与亚洲 ethnicity 在多变量分析中是超过家族史的主要独立危险因素。
  • 亚洲从不吸烟者肺癌基线发病率是非亚洲从不吸烟者的2.3倍。
  • 亚洲女性从不吸烟者肺癌检出率与亚洲男性曾吸烟者相当。
  • 从不吸烟者筛查试验检出率与基于吸烟者的试验相当。

关键数值与推荐

  • 家族史:一级亲属受累者肺癌发病率增高1.7倍。
  • 亚洲从不吸烟者基线肺癌发病率较非亚洲从不吸烟者高2.3倍。
  • PM2.5暴露升高东亚人群LCINS发病与死亡,该地区PM2.5暴露与EGFR突变率均升高。

临床怎么用

  • 对从不吸烟者中的高危亚组(如亚洲女性、有家族史者)应考虑个体化风险评估与筛查讨论。
  • 对LCINS肿瘤应重视可靶向驱动基因检测,因其可指导靶向治疗选择。

局限性

  • 为综述,未报告原始研究样本量、置信区间或P值等定量合并结果。
  • 筛查获益与风险分层策略尚需前瞻性研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Lung cancer in never smokers (LCINS) disproportionately affects younger women and East Asian populations and is characterized by distinct genetic susceptibility, environmental exposures, and molecular alterations. However, never smokers remain excluded from current screening guidelines despite rising incidence and identifiable high-risk subgroups. Family history confers substantial risk, with affected first-degree relatives having 1.7-fold higher incidence, whereas genome-wide association studies and polygenic risk scores further refine genetic susceptibility. Female sex and Asian ethnicity are primary independent risk factors, exceeding family history in multivariable analysis. Asian never smokers have a 2.3-fold higher baseline incidence of lung cancer than non-Asian never smokers, and Asian female never smokers exhibit lung cancer detection rates comparable to Asian male ever smokers. Screening trials in never smokers demonstrated detection rates comparable to smoker-based trials, suggesting certain demographic subgroups may reach risk thresholds where screening could be beneficial. Environmental exposure to particulate matter less than or equal to 2.5 μm in aerodynamic diameter increases LCINS incidence and mortality in East Asian populations where both exposure to particulate matter less than or equal to 2.5 μm in aerodynamic diameter and EGFR mutation rates are elevated. Recent evidence implicates mitochondrial DNA mutations in LCINS susceptibility among Asian never smokers, suggesting integration of environmental exposures and molecular biomarkers may improve risk stratification for screening. The high prevalence of actionable oncogenic drivers in LCINS underscores the importance of early detection, as these tumors benefit from targeted therapies whereas immune checkpoint inhibitors responses are often lower. This review summarizes LCINS epidemiology, genetic susceptibility, molecular alterations, environmental risk factors, and tumor immunology, highlighting the need for greater focus on this underrecognized and growing patient population.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Lu J, Shum E, Samstein RM, et al. Lung Cancer in Never Smokers: Genetics, Epidemiology, Environmental Exposures, and Distinct Immune Landscape. J Thorac Oncol. 2026. PMID: 41932615. doi:10.1016/j.jtho.2026.103709

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。